James Kalabus
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 9
- CAR-T cell therapy research 5
- Drug Transport and Resistance Mechanisms 2
-
- Protease and Inhibitor Mechanisms 3
- Co-authors
- Javier G. Blanco (7 shared papers)Yuzhuo Pan (1 shared paper)Andrew E. Bruno (1 shared paper)Zihua Hu (1 shared paper)Ai‐Ming Yu (1 shared paper)Qiuying Cheng (4 shared papers)Erik Rasmussen (4 shared papers)Thierry Façon (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Drug Metabolism and Disposition (2 papers)Pharmaceutical Research (2 papers)Clinical Cancer Research (1 paper)HemaSphere (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
James Kalabus
21 papers receiving 674 citations
James Kalabus's Hit Papers
Peers
Comparison fields: 5 of 72
- Hematology 207
- Oncology 275
- Cancer Research 113
- Radiology, Nuclear Medicine and Imaging 121
- Immunology 96
Countries citing papers authored by James Kalabus
This map shows the geographic impact of James Kalabus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Kalabus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Kalabus more than expected).
Fields of papers citing papers by James Kalabus
This network shows the impact of papers produced by James Kalabus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Kalabus. The network helps show where James Kalabus may publish in the future.
Co-authors
The 25 scholars most cited alongside James Kalabus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma Hit paper breakdown → | 2020 | 242 |
| 2 | 2012 | 149 | |
| 3 | 2019 | 46 | |
| 4 | 2008 | 33 | |
| 5 | 2023 | 32 | |
| 6 | 2008 | 32 | |
| 7 | 2010 | 23 | |
| 8 | 2012 | 23 | |
| 9 | 2019 | 20 | |
| 10 | 2014 | 17 | |
| 11 | 2020 | 16 | |
| 12 | 2011 | 15 | |
| 13 | 2012 | 15 | |
| 14 | 2020 | 9 | |
| 15 | 2016 | 7 | |
| 16 | 2024 | 5 | |
| 17 | 2019 | 2 | |
| 18 | 2019 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2021 | 1 |
About James Kalabus
James Kalabus is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 22 papers that have together received 690 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Aldose Reductase and Taurine (4 papers), Multiple Myeloma Research and Treatments (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Protease and Inhibitor Mechanisms (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Hematology (207 citations), Oncology (275 citations), Cancer Research (113 citations), Radiology, Nuclear Medicine and Imaging (121 citations) and Immunology (96 citations). James Kalabus has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Javier G. Blanco, Yuzhuo Pan, Andrew E. Bruno, Zihua Hu, Ai‐Ming Yu, Qiuying Cheng, Erik Rasmussen, Thierry Façon, Gerhard Zugmaier and Hermann Einsele. Their work appears in journals such as Journal of Clinical Oncology, Drug Metabolism and Disposition, Pharmaceutical Research, Clinical Cancer Research and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.